|Day Low/High||8.10 / 8.87|
|52 Wk Low/High||2.00 / 10.24|
Nivalis Therapeutics, Inc. (NASDAQ: NVLS), a pharmaceutical company historically focused on developing innovative solutions for people with cystic fibrosis (CF), today reported financial results and recent...
Alpine Immune Sciences, a cancer immunotherapy company founded by former Dendreon CEO Mitch Gold, is listing publicly through a merger with Nivalis Therapeutics.
Nivalis Therapeutics, Inc. (NASDAQ: NVLS) and Alpine Immune Sciences, Inc.
Review of Strategic Alternatives Progressing as Operations Streamlined
Here's a technical look at how to trade several under-$10 stocks triggering breakout trades.
Levi & Korsinsky announces it has commenced an investigation of Nivalis Therapeutics, Inc.
Company to Host Conference Call Today, November 28, at 5:00 p.m. EST
Completion of Enrollment in Phase 2 Study of Cavosonstat for Treatment of Cystic Fibrosis Achieved During the Quarter
Here's a technical look at how to trade several under-$10 stocks that were making big moves to the upside recently.
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Company on track to report results from the study in fourth quarter this year